Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Sydney’s Delta Surge Prompts Tougher Lockdown Restrictions

Published 07/28/2021, 09:56 PM
Updated 07/28/2021, 10:00 PM
© Reuters.  Sydney’s Delta Surge Prompts Tougher Lockdown Restrictions

(Bloomberg) -- Sydney’s delta-outbreak cases have reached a new peak even as the Australian city nears the end of its fifth week under strict stay-at-home orders, triggering authorities to implement further restrictions and penalties to enforce compliance.

New South Wales, Australia’s biggest state economy, recorded 239 new cases Thursday -- the highest tally since this outbreak started in Sydney in mid-June and up from 177 the day before. At least 70 cases were active in the community while infectious, concerning health officials that the delta-variant of the coronavirus may further spread in the city of almost 6 million people.

“Based on those numbers, we can only assume that things are likely to get worse before they get better,” New South Wales state Premier Gladys Berejiklian told reporters on Thursday. Two more people had died, she said.

Berejikian said mask-wearing in public would be mandated for the city’s worst-hit areas, with penalties increased from a A$200 ($147) fine to A$500. Stricter travel restrictions will be implemented, and thousands of additional police officers are being tasked with ensuring compliance.

On Wednesday, Berejiklian confirmed the city’s lockdown will be implemented for at least nine weeks, after being extended for a third time until August 28. The restrictions began on June 26, when 12 new cases were recorded in the local community. The city’s outbreak has since swelled -- fueled by the spread of the highly-contagious delta variant -- with nearly 3,000 cases reported since mid-June.

The outbreak is highlighting the problems with Australia’s so-called Covid Zero strategy to keep the virus out of local communities amid a tardy vaccine roll-out, which has been hit by supply-chain hold-ups from contracted drug-makers. Political rivals also say that Prime Minister Scott Morrison failed to secure enough doses from a wide-enough range of suppliers.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Earlier in July, Morrison said state and territory leaders had agreed to map out a pathway to switch from virus suppression to focus on reducing the risk of serious illness and hospitalization, depending on high vaccination rates that are yet to be determined.

While the National Cabinet will meet Friday to again discuss the nation’s exit strategy from Covid Zero, Morrison has indicated he’s unlikely to announce the vaccination targets needed to start opening back up for several weeks.

In the meantime, his conservative government is spending about A$750 million a week on support for businesses and workers in New South Wales, and some economists are forecasting the Sydney lockdown will trigger an economic contraction in the third quarter.

(Update with economic cost in final paragraph.)

©2021 Bloomberg L.P.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.